Amphastar Pharmaceuticals Change in Payables and Accrued Expense (Quarterly) Analysis

Amphastar Pharmaceuticals, Inc. (AMPH)

27.65 +0.10 (+0.36%) USD | NASDAQ | Feb 24, 16:00

27.65 0.00 (0.00%) After-Hours: 17:26

View Change in Payables and Accrued Expense (Quarterly) for AMPH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Change in Payables and Accrued Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Change in Payables and Accrued Expense (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Pfizer Inc.	--
Organon & Co.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
CorMedix, Inc.	Upgrade